Denali Therapeutics, Inc. (DNLI)
24.00
-0.67
(-2.72%)
USD |
NASDAQ |
Aug 28, 16:00
24.05
+0.05
(+0.21%)
After-Hours: 05:18
Denali Therapeutics Cash and Short Term Investments (Quarterly) : 710.47M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 710.47M |
| March 31, 2026 | 987.68M |
| December 31, 2025 | 867.88M |
| September 30, 2025 | 848.20M |
| June 30, 2025 | 898.95M |
| March 31, 2025 | 817.93M |
| December 31, 2024 | 832.33M |
| September 30, 2024 | 836.56M |
| June 30, 2024 | 896.04M |
| March 31, 2024 | 936.87M |
| December 31, 2023 | 1.035B |
| September 30, 2023 | 1.109B |
| June 30, 2023 | 1.191B |
| March 31, 2023 | 1.288B |
| December 31, 2022 | 1.336B |
| September 30, 2022 | 1.106B |
| June 30, 2022 | 1.069B |
| March 31, 2022 | 957.52M |
| December 31, 2021 | 865.41M |
| September 30, 2021 | 1.039B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.309B |
| March 31, 2021 | 1.413B |
| December 31, 2020 | 1.470B |
| September 30, 2020 | 961.20M |
| June 30, 2020 | 549.58M |
| March 31, 2020 | 587.25M |
| December 31, 2019 | 415.36M |
| September 30, 2019 | 479.39M |
| June 30, 2019 | 478.60M |
| March 31, 2019 | 485.48M |
| December 31, 2018 | 464.30M |
| September 30, 2018 | 374.96M |
| June 30, 2018 | 372.59M |
| March 31, 2018 | 373.40M |
| December 31, 2017 | 406.23M |
| September 30, 2017 | 185.80M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 178.33M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Anixa Biosciences, Inc. | 13.69M |